Medical audit in a district general hospital coronary care unit led to the introduction of an emergency cardiac enzyme service. 91.2% of patients eligible for thrombolysis therapy received treatment following this introduction compared to 73.7% before (P=.05). No patient was treated inappropriately on the basis of a raised cardiac enzyme.
Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardio (GISSI).Effectiveness of thrombolytic treatment in acute myocardial infarction. Lancet1986; i: 397–401
2.
ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of acute myocardial infarctionLancet1988; ii: 349–60
3.
AIMS Trial Study Group.Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet1988; i: 545–9
4.
ASSET Study Group.Trial of Tissue Plasminogen Activator for Mortality Reduction in Acute Myocardial Infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet1988; ii: 525–30
5.
SidneyB., RosalkiJ.Enzyme assays in diseases of the heart and skeletal muscle. J Clin Pathol1970; 24(Suppl 4): 60–70
6.
LeeT.H., WeisbergM.C., CookE.F.Evaluation of CK and CK-MB for diagnosing myocardial infarction. Clinical impact in the emergency room. Arch Intern Med1987; 147: 115–21
7.
EisenbergJ.M., HorowitzL.N., BuschR.Diagnosis of acute myocardial infarction in the emergency room. A prospective assessment of clinical decision making and the usefulness of immediate cardiac enzyme determination. J Community Health1979; 4: 190–8
